Back to rankings
England - London • TMT (technology, media and telecoms)
1

Intellectual property: patents (contentious and non-contentious)

Simmons & Simmons logo

Simmons & Simmons

More information
With vast experience representing a prestigious client base in various types of patent disputes, the team at Simmons & Simmons turns its hand to matters in the life sciences, telecoms, tech, engineering and healthcare sectors, devising IP strategies and negotiating high-value R&D, collaboration, and other commercial agreements for clients in innovative industries. Practice head Kevin Cordina is noted for his expertise in patent prosecution and contentious matters, and Scott Parker is a key name for pharma and biotech litigation. On the transactional side are licensing, collaborations, and regulatory specialist Michael Gavey, and Angus McLean, who focuses on emerging technologies. Priya Nagpal‘s practice encompasses patent disputes connected to disruptive technologies. Lydia Torne is noted for licensing advice in the health, medical tech, and life sciences space, and Elsa Glauert takes on contentious work in the same sectors. Joel Smith joined from Hogan Lovells International LLP in 2024.
Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘I have been working with Simmons & Simmons for a number of years. When it comes to digital health issues, like IP, data protection, and related rules and legislation, Simmons  & Simmons really know their stuff.’

  • ‘Priya Nagpal is my key contact at Simmons. Priya is a strategic and insightful IP litigator. Priya has great experience and insight, and consistently devises sophisticated and effective strategies to navigate intricate IP challenges. Moreover, her collaborative nature makes her a delight to work with. Priya is backed by an excellent team.'

  • 'The team puts effort into learning and understanding the priorities of us as a client, which makes it much easier to initiate new tasks and heightens the value of the work provided.'

  • 'Michael Gavey is knowledgeable of the life sciences sector and has always been able to include relevant associates for different topics.'

Key clients

  • Boston Scientific Corporation
  • Samsung Bioepis
  • Apple
  • GSK
  • Amgen
  • AstraZeneca
  • Merck Sharp & Dohme
  • J&J
  • Alnylam
  • Roche
  • Regeneron
  • Pfizer

Work highlights

Advised Ascendis Pharma on its exclusive worldwide licence to Novo Nordisk for the TransCon technology platform to develop, manufacture and commercialise Novo Nordisk's proprietary products in metabolic diseases.
Advised GSK in connection with the negotiation and drafting of its collaboration agreement with Muna Therapeutics to identify, develop and commercialise drug targets for the treatment of Alzheimer’s Disease.
Advised Samsung Bioepis with the UK patent revocation action and broader European strategy concerning pre-filled syringes of Lucentis/Ranibizumab.

Practice head

Kevin Cordina

Other key lawyers

Scott Parker; Michael Gavey; Angus McLean; Priya Nagpal; Lydia Torne; Elsa Glauert; Joel Smith